Stockscreener 앱 받기
6.456
1.35%
0.086
전일 마감가:
$6.37
열려 있는:
$6.16
하루 거래량:
8,121
Relative Volume:
0.52
시가총액:
$4.16M
수익:
-
순이익/손실:
$-11.27M
주가수익비율:
-0.3015
EPS:
-21.4132
순현금흐름:
$-9.40M
1주 성능:
+0.09%
1개월 성능:
+2.48%
6개월 성능:
-43.86%
1년 성능:
-75.36%
1일 변동 폭
$6.12
$6.6739
1주일 범위
$5.94
$7.14
52주 변동 폭
$5.739
$28.80
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
DRMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
6.456 | 4.16M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
Using data models to predict Dermata Therapeutics Inc. stock movementAI Generated Momentum Stock Forecast Guide - Newser
Candlestick signals on Dermata Therapeutics Inc. Equity Warrant stock todayROI Focused Setup Screener With Exit Markers - Newser
What the charts say about Dermata Therapeutics Inc. todayFree Entry Points For Growing Stocks - Newser
How to interpret RSI for Dermata Therapeutics Inc. stockFree Exit Ready Momentum Stock Watchlist - Newser
What data driven models say about Dermata Therapeutics Inc. Equity Warrant’s futurePredictable Return Strategy with AI Support - Newser
Is Dermata Therapeutics Inc. showing signs of accumulationFree Secure Capital Picks With Upside Potential - Newser
Leading vs lagging indicators on Dermata Therapeutics Inc. Equity Warrant performanceDaily Stock Movement Forecast with Accuracy - Newser
How to use a screener to detect Dermata Therapeutics Inc. Equity Warrant breakoutsFree Trade Setups With Clear Risk Limits - Newser
Dermata Therapeutics, Inc. (NASDAQ:DRMA) Short Interest Up 49.9% in July - Defense World
How to forecast Dermata Therapeutics Inc. Equity Warrant trends using time seriesLow Drawdown Picks with Weekly Updates - Newser
Heatmap analysis for Dermata Therapeutics Inc. Equity Warrant and competitorsLow Risk Strategy with Smart Entry Zones - Newser
Using fundamentals and technicals on Dermata Therapeutics Inc.Controlled Entry Strategy With Safety Analytics - Newser
Published on: 2025-08-08 02:17:04 - Newser
Will Dermata Therapeutics Inc. continue its uptrendStock Forecast Tools for Retail Traders - Newser
Real time pattern detection on Dermata Therapeutics Inc. Equity Warrant stock - Newser
Volume spikes in Dermata Therapeutics Inc. Equity Warrant stock – what they meanSmart Chart Forecasting with AI Algorithms - Newser
Reversal indicators forming on Dermata Therapeutics Inc. Equity Warrant stockIntraday Signal Forecast for Fast Traders - Newser
Momentum divergence signals in Dermata Therapeutics Inc. chartShort-Term Support and Resistance Forecast - Newser
Will Dermata Therapeutics Inc. bounce back from current supportFree Triple Digit Return Stock Predictions - Newser
Dermata Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingAI-Based Stock Behavior Forecast Engine - Newser
Moving Average Trends for Dermata Therapeutics Inc. Equity Warrant Stock: What They IndicateLow Risk Strategy with Smart Entry Zones - Newser
When is the best time to buy Dermata Therapeutics Inc. stockShort-Term Trade Setup with Forecast Insight - Newser
Dermata Therapeutics Inc. Equity Warrant stock volume spike explainedFree Day Trading Signals With High Precision - Newser
Published on: 2025-08-06 19:24:47 - Newser
Is it too late to sell Dermata Therapeutics Inc. Equity WarrantSwing Trade Picks with High Potential - Newser
Can a trend reversal in Dermata Therapeutics Inc. Equity Warrant lead to recoveryBuy Alert Based on RSI and Volume - Newser
Will Dermata Therapeutics Inc. Equity Warrant continue its uptrendWeekly Growth Portfolio Performance Summary - Newser
Will Dermata Therapeutics Inc. Equity Warrant Stock Benefit from AI and Green Energy TrendsFree Price Action Based Buy Opportunity List - Newser
Analyzing recovery setups for Dermata Therapeutics Inc. investorsWealth Accumulation Outlook for Safe Investors - Newser
Why Dermata Therapeutics Inc. Equity Warrant stock is on top investor watchlistsTechnical Analysis of Growth Stock Opportunities - Newser
Traders Consider Averaging Down in Dermata Therapeutics Inc.Weekly Watchlist of High Movers Released - metal.it
Published on: 2025-08-04 03:40:20 - Newser
What’s next for Dermata Therapeutics Inc. Equity Warrant stock priceFree Daily Stock Market Swing Alerts - Newser
What is Dermata Therapeutics Inc. company’s growth strategyMarket-beating performance - Jammu Links News
Why is Dermata Therapeutics Inc. Equity Warrant stock attracting strong analyst attentionConsistent wealth multiplication - Jammu Links News
What are the technical indicators suggesting about Dermata Therapeutics Inc. Equity WarrantDynamic profit opportunities - Jammu Links News
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):